Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A -1.15%17 EV-to-FCF is -14.60 as of Jul. 21, 2026. GuruFocus rates TSE:177A with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 338 Biotechnology companies, Kohjin Bio Co ranks worse than 295857.69% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kohjin Bio Co's Enterprise Value is 円4,101 Mil.
Kohjin Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-281 Mil. Therefore, Kohjin Bio Co's EV-to-FCF for today is -14.60.
The historical rank and industry rank for Kohjin Bio Co's EV-to-FCF or its related term are showing as below:
TSE:177A'
s EV-to-FCF Range Over the Past 10 Years
Min: -25.88 Med: 33.34 Max: 290.86
Current: -14.6
During the past 5 years, the highest EV-to-FCF of Kohjin Bio Co was 290.86. The lowest was -25.88. And the median was 33.34.
TSE:177A's EV-to-FCF is ranked worse than 100% of 338
companies
in the Biotechnology industry
Industry Median: 15.02
vs TSE:177A: -14.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kohjin Bio Co's PE Ratio (TTM) for today is calculated as:
Kohjin Bio Co's share price for today is 円860.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kohjin Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円49.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Kohjin Bio Co EV-to-FCF Related Terms
Kohjin Bio Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Kohjin Bio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's EV-to-FCF falls into.
Kohjin Bio Co's current Enterprise Value is 円4,101 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kohjin Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-281 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kohjin Bio Co (TSE:177A) has a EV-to-FCF of -14.60 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Kohjin Bio Co and its competitors. According to the industry distribution chart, Kohjin Bio Co ranks #999999 out of 338 companies in the Biotechnology industry.
Is Kohjin Bio Co's EV-to-FCF too high?
Kohjin Bio Co's current EV-to-FCF is -14.60. Based on the distribution chart, Kohjin Bio Co ranks #999999 out of 338 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #999999 out of 338 companies for EV-to-FCF. This places Kohjin Bio Co in the lower half of its industry. The industry median EV-to-FCF is 15.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.02, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current EV-to-FCF is -14.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current EV-to-FCF of -14.60. The current EV-to-FCF is -14.60. Kohjin Bio Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current EV-to-FCF is -14.60 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
17GF Score
Get the complete analysis for TSE:177A
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
